Thyroid Cancer Newswire

Thyroid Cancer Newswire

Comprehensive Real-Time News Feed for Thyroid Cancer.

Results 1 - 20 of 911 in Thyroid Cancer

  1. Overdiagnosis in cancer.Read the original story

    5 hrs ago | CiteULike

    ... cancer statistics suggesting overdiagnosis in computed tomography-detected lung cancer, neuroblastoma, thyroid cancer, melanoma, and kidney cancer. To address the problem, patients must be adequately informed of the nature and the magnitude of the ...

    Comment?

  2. Castle Biosciences Announces the Appointment of Veracyte CEO Bonnie...Read the original story

    17 hrs ago | Freshnews

    ... of Veracyte's first product, the Afirma Thyroid FNA Analysis, which is becoming a new standard of care in thyroid cancer diagnosis. The company also recently entered the pulmonology market with the launch of Percepta Bronchial Genomic Classifier to ...

    Comment?

  3. Rates of thyroid cancer tripled since 1975 - public water utilities...Read the original story w/Photo

    20 hrs ago | UK Against Fluoridation

    A study published last year attempted to explain away the thyroid cancer epidemic in the U.S. today, blaming it not on more actual cases of the disease, but rather on more diagnoses . The problem, say researchers from Dartmouth University, is that thyroid cancer is supposedly overdiagnosed and overtreated.

    Comment?

  4. People With Thyroid Cancer in The Nordic Region Now Able to Benefit...Read the original story

    Sunday | Sys-Con Media

    Launch delivers important new treatment option for advanced thyroid cancer following significant progression-free survival data from the SELECT trial LenvimaA , a treatment for people with radioactive iodine refractory differentiated thyroid cancer , launches in in the Nordic region. Advanced thyroid cancer is a difficult to treat condition with a poor prognosis and Lenvima represents a significant advance for patients in the Nordic countries.

    Comment?

  5. Orphan drugs market sees AbbVie and Actelion Pharmaceuticals become major playersRead the original story w/Photo

    Sunday | PR-inside.com

    The global market for orphan drugs is driven by the ever-increasing discovery of orphan or rare diseases, predominantly rare cancers, such as renal cell carcinoma, non-small cell lung cancer, acute myeloid leukemia, and thyroid cancer, among others. The lack of appropriate therapies for orphan diseases and the legislative benefits offered by the government for orphan drug development are attracting major pharmaceutical companies to venture into this arena.

    Comment?

  6. Veracyte Inc (VCYT) Jumps On New Aetna Inc. (AET) Deal: Is It A Good Stock To Buy?Read the original story w/Photo

    Sunday | Insider Monkey

    ... cytology field. Its flagship product is the Afirma Thyroid FNA analysis which is a test that is part of thyroid cancer diagnosis when benign thyroid nodules among those deemed unclassified by cytopathology are needed to be identified. BTIG Research ...

    Comment?

  7. Environment: EPA finally agrees to study impacts of common pesticides on 1,500 endangered speciesRead the original story w/Photo

    Sunday | Summit County Voice

    ... addition to causing severe harm to endangered species, atrazine exposure may be linked to increased risks of thyroid cancer, reproductive harm and birth defects in people. A recent study showed that children whose mothers were exposed to atrazine ...

    Comment?

  8. Biotech Stock Mailbag: Exelixis, Puma BioRead the original story w/Photo

    Friday Jun 26 | TheStreet.com

    ... following the failure of prostate cancer studies last year. Cometriq is approved as a treatment for medullary thyroid cancer but generated just $25 million in 2014 sales because the targeted patient population is so small. The METEOR study enrolled ...

    Comment?

  9. Veracyte, Inc. Announces National Network Agreement WithRead the original story

    Thursday Jun 25 | BioSpace

    The test is used as part of thyroid cancer diagnosis when it is medically necessary to identify benign thyroid nodules among those deemed indeterminate by cytopathology, potentially enabling patients to avoid an unnecessary surgery. , with more than 62,000 new cases expected in 2015.

    Comment?

  10. Veracyte enters into national network agreement with AetnaRead the original story

    Friday Jun 26 | M2.com

    Diagnostics company Veracyte disclosed on Thursday an agreement to join Aetna's laboratory network with effect from 1 July 2015. According to Veracyte, it administers the Afirma Thyroid FNA analysis as part of thyroid cancer diagnosis when it is medically necessary to identify benign thyroid nodules among those deemed indeterminate by cytopathology, potentially enabling patients to avoid an unnecessary surgery.

    Comment?

  11. Biotech columnist Adam Feuerstein answers readers' questions about health care.Read the original story w/Photo

    Friday Jun 26 | TheStreet.com

    ... following the failure of prostate cancer studies last year. Cometriq is approved as a treatment for medullary thyroid cancer but generated just $25 million in 2014 sales because the targeted patient population is so small. The METEOR study enrolled ...

    Comment?

  12. High-performance microscope displays pores in the cell nucleus with greater precisionRead the original story w/Photo

    Friday Jun 26 | Science, Industry and Business

    ... some diseases that involve a defective transportation to the nuclear pores - such as intestinal, ovarian and thyroid cancer. M. Eibauer, M. Pellanda, Y. Turgay, A. Dubrovsky, A. Wild, and O. Medalia: Structure and Gating of the Nuclear Pore Complex. ...

    Comment?

  13. Veracyte Announces National Network Agreement with AetnaRead the original story

    Thursday Jun 25 | Freshnews

    ... ) Thyroid FNA analysis, a proprietary Gene Expression Classifier (GEC) test. The test is used as part of thyroid cancer diagnosis when it is medically necessary to identify benign thyroid nodules among those deemed indeterminate by cytopathology, ...

    Comment?

  14. Can your hospital count on you?Read the original story w/Photo

    Wednesday Jun 24 | DurhamRegion.com

    ... into the world just one year later. A month and a half after his daughter was born, Perry was told he had thyroid cancer. Perry needed radioactive iodine therapy, a treatment he would receive at Lakeridge Health's leading Cancer Centre. ...

    Comment?

  15. Rod Stewart's voice changed with cancer treatmentRead the original story w/Photo

    Wednesday Jun 24 | National Ledger

    Rod Stewart's voice is an octave lower since he was treated for thyroid cancer. The 70-year-old received treatment on his thyroid gland in 2001 during a cancer scare and revealed while he was relieved he could still sing following the operation, it did result in him having a deeper voice.

    Comment?

  16. Rod Stewart: I couldn't boil egg to save my lifeRead the original story

    Wednesday Jun 24 | Scotsman.com

    ... out Fifa," he said of football's troubled international governing body. Stewart said of being treated for thyroid cancer several years ago: "I couldn't sing for about three weeks. But the voice came back, albeit an octave lower, so I sing a little ...

    Comment?

  17. New Study: OXiGENE, Inc. (OXGN) - Pharmaceuticals & Healthcare - Deals and Alliances ProfileRead the original story

    Wednesday Jun 24 | PR-inside.com

    ... tubulin binding agent, which is in Phase II clinical trials for the treatment of ovarian cancer, anaplastic thyroid cancer, medullary thyroid cancer, stage IV papillary thyroid cancer, and stage IV follicular thyroid cancer. The company also offers ...

    Comment?

  18. Chemical soupRead the original story w/Photo

    Wednesday Jun 24 | San Mateo Daily Journal

    ... "Almost 30 years ago, the acting director of the FDA said that this dye should be banned because it caused thyroid cancer in animals. But politics overrode science, and the FDA, under both Democrats and Republicans, has done absolutely nothing, ...

    Comment?

  19. Rod Stewart hailed Taylor Swift's stance on AppleRead the original story w/Photo

    Wednesday Jun 24 | Bury Times

    ... out Fifa," he said of football's troubled international governing body. Stewart said of being treated for thyroid cancer several years ago: "I couldn't sing for about three weeks. But the voice came back, albeit an octave lower, so I sing a little ...

    Comment?

  20. Rod Stewart: I agree that cooking makes men less masculine... I can't even boil an eggRead the original story w/Photo

    Wednesday Jun 24 | Sunday Herald

    ... out Fifa," he said of football's troubled international governing body. Stewart said of being treated for thyroid cancer several years ago: "I couldn't sing for about three weeks. But the voice came back, albeit an octave lower, so I sing a little ...

    Comment?